Records containing: Rosacea
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2017-01-13Patient-Reported Outcomes of Brimonidine Tartrate 0.5% Gel for Treatment of Severe Facial Erythema of Rosacea
-
CLINICAL_TRIALS study record update · 2016-10-20Effect of CD07805/47 Gel in Subjects Presenting With Flushing Related to Erythematotelangiectatic or Papulopustular Rosacea
-
CLINICAL_TRIALS study record update · 2016-09-21A Long-term Safety and Efficacy Study of Oxymetazoline HCl Cream 1.0% in Patients With Persistent Erythema Associated With Rosacea
-
CLINICAL_TRIALS study record update · 2016-09-20Multicenter, Randomized, Double-blind, Placebo-controlled Parallel-group, Dose Finding Phase II Clinical Trial to Evaluate Anti Rosacea Effect and Safety of PAC-14028 Cream (0.1%, 0.3%, 1.0%) in Rosacea Patients
-
CLINICAL_TRIALS study record update · 2016-08-02ClinicalTrials.gov study NCT02132117
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2016-03-10ClinicalTrials.gov study NCT02131636
-
CLINICAL_TRIALS study record update · 2015-11-02An Eight-Week, Multi-Site, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group Trial to Evaluate the Safety, Tolerability, and Effects of Anatabloc® Crème in Subjects With Rosacea Followed by an Open-Label Extension
-
CLINICAL_TRIALS study record update · 2015-09-23Investigation of Relation Between Demodex Density With Immune Response and Oxidative Stress in Rosacea Patients
-
CLINICAL_TRIALS study record update · 2015-08-26Pilot, Randomized, Double Blind, Placebo Controlled, Parallel Group, Dose Range Finding Study, to Evaluate the Tolerability and Safety of FXFM244 Antibiotic Foam and to Monitor Its Clinical Effect in Moderate to Severe Rosacea Patients
-
CLINICAL_TRIALS study record update · 2015-03-25A Randomized, Double-blind, Placebo-controlled, Multi-center, Parallel Group Study to Assess the Pharmacodynamics of MK-0524 in Subjects With Moderate to Severe Erythematotelangiectatic Rosacea. (Protocol No. 155)
-
CLINICAL_TRIALS study record update · 2015-01-13a Randomised, Double Blind, Placebo Controlled, Half- Face Study to Evaluate the Effect of Topical Ivermectin Cream 0.5% on Demodicidosis
-
CLINICAL_TRIALS study record update · 2015-01-09A Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Dose-Range Study of DER 45 EV Gel, 1% and 5%, and Vehicle Gel in the Treatment of Rosacea
-
CLINICAL_TRIALS study record update · 2014-11-17Assessment of the Prevalence of Rosacea in the General Population
-
CLINICAL_TRIALS study record update · 2014-11-17Rosacea Prevalence in General Population - Pilot Study
-
CLINICAL_TRIALS study record update · 2014-10-20ClinicalTrials.gov study NCT01789775
-
CLINICAL_TRIALS study record update · 2014-08-11Safety and Efficacy Evaluation of the Luxe™ Device for the Treatment of Facial Wrinkles and Rosacea
-
CLINICAL_TRIALS study record update · 2014-08-05A Multicenter, Randomized, Double-blind, Placebo-controlled Evaluation of Rosacea-related Inflammatory Biochemical Markers in the Skin of Adults With Papulopustular Rosacea Treated With Daily Doxycycline 40 mg (30 mg Immediate Release / 10 mg Delayed Release Beads) Capsules
-
CLINICAL_TRIALS study record update · 2014-08-04Evaluation of Relapse, Efficacy and Safety of Long-term Treatment With Oracea® Capsules Compared to Placebo After an Initial 12 Week Treatment Regimen With Oracea® and MetroGel® 1% in Adults With Rosacea
-
CLINICAL_TRIALS study record update · 2014-07-16Investigation of the Topical Retinoid, Atralin Gel 0.05% for the Treatment of Erythematotelangiectatic Rosacea
-
CLINICAL_TRIALS study record update · 2014-07-10A Multicenter, Randomized, Controlled, Double-masked, Crossover Design Study to Compare Efficacy and Assess Safety of CD07805/47 Gel 0.5% Applied Once Daily vs Azelaic Acid Gel 15% Applied Twice Daily in Subjects With Erythema of Rosacea
-
CLINICAL_TRIALS study record update · 2014-05-30ClinicalTrials.gov study NCT01735201
-
CLINICAL_TRIALS study record update · 2014-05-29A Multicenter Randomized Evaluator-Blinded Vehicle-Controlled Parallel Group Evaluation of Twice Daily PDI-320 in Comparison to Its Monads in Adults With Rosacea
-
CLINICAL_TRIALS study record update · 2014-04-28Rifaximin Treatment of Papulopustular Rosacea: Double- Blinded, Placebo-Controlled, Crossover Study
-
CLINICAL_TRIALS study record update · 2014-03-11A 4-week, Randomized, Double-blind, Parallel-group, Vehicle-controlled, Multicenter Study Investigating the Efficacy and Safety of CD07805/47 Gel 0.5% Applied Topically Once Daily (QD), and CD07805/47 Gel 0.18% Applied Topically Once Daily (QD) or Twice Daily (BID), in Subjects With Moderate to Severe Facial Erythema Associated With Rosacea
-
CLINICAL_TRIALS study record update · 2014-01-08A Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of CD07805/47 Gel 0.5% Applied Topically Once Daily for up to 52 Weeks in Subjects With Moderate to Severe Facial Erythema Associated With Rosacea